Shoni Health Ventures

2 stories about Shoni Health Ventures
Eran Shoni

Drug development has a $2 billion problem. AI is finally solving it

07.08.26|Eran Lerer
Most clinical trials still fail, but what if AI simulated studies could change the odds? Eran Lerer, Managing Partner of Shoni Health Ventures explains why trial simulation is becoming pharma's new default.
Eran Shoni

Shoni Health Ventures outlines the landscape of opportunities and challenges in 2025

06.01.25|James Spiro, Elihay Vidal
CEO and Managing Partner Eran Lerer joined CTech to share insights on the year ahead and how HealthTech will be impacted.